NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Avelas Biosciences

Avelas Biosciences

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://avelasbio.com

Last Round

Accelerator

Jun 17, 2019

Total Funding Raised

$35.05M

Company Overview

Avelas Biosciences is a biotechnology company that develops fluorescent imaging technologies for real-time cancer detection and visualization during surgery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Imaging, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

intraoperative imagingfluorescence imagingcancer surgerymolecular imagingtumor margin detectionimage-guided surgeryfluorescent peptidesurgical oncologybiotechdrug-device combinationpegloprastidesurgical visualizationreal-time diagnosticsprecision surgerysurgical tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Avelas Biosciences Comps

Public and private peers based on sector, stage, and business model.

Avelas Biosciences comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Avelas Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 17, 2019
Series CAug 18, 2016
Series BSep 10, 2014
Series ADec 6, 2012

Avelas Biosciences Investors

Notable investors and investment history

Avelas Biosciences investors
InvestorRounds
MedTech InnovatorAccelerator
WuXi Healthcare VenturesSeries C
Avalon VenturesSeries C, Series A, Series B
Torrey Pines Investment LLCSeries B
Alexandria Venture InvestmentsSeries C
Pharmstandard International S.A.Series C

Avelas Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Avelas Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Avelas Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range2
Year Founded2008
Last FundingJun 17, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.